Cargando…
HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research
A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HI...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute on Drug Abuse
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851052/ https://www.ncbi.nlm.nih.gov/pubmed/18567957 |
_version_ | 1782179845338300416 |
---|---|
author | Sorensen, James L. Masson, Carmen L. Perlman, David C. |
author_facet | Sorensen, James L. Masson, Carmen L. Perlman, David C. |
author_sort | Sorensen, James L. |
collection | PubMed |
description | A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HIV or hepatitis infection and to limit the consequences for patients who are already infected. Drug treatment programs can play a pivotal role in preventing, detecting, and treating HIV and hepatitis. Some activities can be accomplished by providers’ simply becoming aware of the issues; others will require significant infusion of leadership, education, and fiscal support. |
format | Text |
id | pubmed-2851052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | National Institute on Drug Abuse |
record_format | MEDLINE/PubMed |
spelling | pubmed-28510522010-10-25 HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research Sorensen, James L. Masson, Carmen L. Perlman, David C. Sci Pract Perspect Research Review A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HIV or hepatitis infection and to limit the consequences for patients who are already infected. Drug treatment programs can play a pivotal role in preventing, detecting, and treating HIV and hepatitis. Some activities can be accomplished by providers’ simply becoming aware of the issues; others will require significant infusion of leadership, education, and fiscal support. National Institute on Drug Abuse 2002-07 /pmc/articles/PMC2851052/ /pubmed/18567957 Text en |
spellingShingle | Research Review Sorensen, James L. Masson, Carmen L. Perlman, David C. HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research |
title | HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research |
title_full | HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research |
title_fullStr | HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research |
title_full_unstemmed | HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research |
title_short | HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research |
title_sort | hiv/hepatitis prevention in drug abuse treatment programs: guidance from research |
topic | Research Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851052/ https://www.ncbi.nlm.nih.gov/pubmed/18567957 |
work_keys_str_mv | AT sorensenjamesl hivhepatitispreventionindrugabusetreatmentprogramsguidancefromresearch AT massoncarmenl hivhepatitispreventionindrugabusetreatmentprogramsguidancefromresearch AT perlmandavidc hivhepatitispreventionindrugabusetreatmentprogramsguidancefromresearch |